©2024 Lysando

All rights reserved

Happy mother with child in her arms at the beach

Discover our novel methods for combating bacterial infections

Your Life is
Our Priority

Multiresistance has spread globally, causing millions of deaths annually.

Infections disrupt the microbiome, allowing harmful bacteria to overgrow.

Artilysin restores the microbiom’s healthy balance.

View More

Let’s redefine our future.
For a Healthier Tomorrow.

By 2050, antimicrobial-resistant infections could lead to as many as 10 million deaths per year-ten times the current rate.

* Based on United Nations report World Population Prospects: The 2015 Revision, 2015

Lysando spent over 10 years of research and development with the global of breaking this ever-accelerating cycle of resistance.

Deaths from antimicrobial infections

A Breakthrough
in the Fight Against
Antibiotic
Resistance

A technology based on specifically engineered proteins that employ the law of physicis. Artilysin´s mode of action does not require specific receptors, nor an active bacterial metabolism.

The Key: Artilysin®
Our Extensively Patented Technology

Artilysin® is a groundbreaking antimicrobial platform technology engineered to target and combat bacterial pathogens across a wide array of applications.

Artilysin® molecules are tailor-made for each application. With Lysandos focus on each bacterial indication leading to effective and safe proteins.

Artilysin® is capable of targeting nearly all bacterial species and is highly effective against resistant , highly resistant and persistent bacterial strains.

Artilysin® effectively eradicates untreatable bacterial infections.

Learn more

We have paved the way. 
Now it’s time to move forward together.

When we embarked on our research in 2009, we could not have anticipated the revolutionary impact of our inventions. We are now on the brink of making a significant difference for millions of people globally.

The moment to share our progress has arrived, and we are thrilled to have you join us on this journey!

14
Years of development

Our technology is backed by over a decade of comprehensive research, 14 years of experience, rigorous testing, expert knowledge and over 300 patents, all of which form the foundation of its results.

450
Prototypes

More than 450 effective prototypes demonstrate the potential of Artilysin for treating a range of bacterial infections. From inflammatory open wounds to atopic dermatitis, the solution is already here.

290
Patents

Our patents allow us to operate independently and with full autonomy in our technological pursuits. This freedom enables us to focus on our primary goal: enhancing your health.

Markus Graf Matuschka von Greiffenclau, CEO

Our technology will save countless lives and sustainably improve people’s health and wellbeing.

By curing them, not just treating them.

Markus Graf Matuschka von Greiffenclau, CEO

We Are Convinced

The Artilysin® approach is predestined to become a true game changer and revolutionize modern acne treatment.

Priv.-Doz. Dr. med.
Wolfgang G. Philipp-Dormston

My hands are completely healed. For the first time in years I’m taking active part in everyday life without any pain and discomfort.

Mrs. Christa Ostertag,
Atopic dermatitis (Eczema) cure trial

I believe in Lysando’s mission to tackle global antimicrobial resistance and enhance patient outcomes, working together to create a healthier future through science and innovation!

Jorge Cortell
Senior Advisor for Healthcare and Life Sciences, Harvard Innovation Labs

Artilysin® has been a game-changer in my acne journey! Stay tuned for updates from Lysando – it has the potential to make an unbelievable difference in your life too!

Mrs. S.

It doesn’t happen often in a life to get in touch with something that will make everybody’s life so much better so I encourage all of us to engage with this something!

Prof. Wolfram Winter,
Public Relations & Communications Expert

For you, we give our best at every step.

Since our establishment in 2009, we have dedicated ourselves to advancing our Artilysin platform technology. While we have achieved significant milestones, we are just beginning. Join us on this journey and contribute to making the world a safer place.

Our team is guided by a diverse and accomplished advisory board, bringing together experts from various fields.

Our advisory board, comprised of visionaries and thought leaders, provides invaluable insights, steering us toward innovation and excellence.

Meet the minds shaping our journey:

We bring together scientists from all over the world.

From the beginning, it was their vision and courage that enabled us to develop Artilysin® as an alternative to antibiotics – and lead it to success.

show all locations

We Have
the Solution.
You Have
the Choice.

Our technology will save millions of lives – but only if everyone gets equal access to it. To make that happen, we need your help to stay independent of financial interests.

Here’s how you can support us:

Become a future shareholder and subscribe to our newsletter now. We will inform you about all further steps and let you know when you can purchase shares.

Side by Side –
for a New Medical Era and a Real Change in the World.